Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cognitive Dysfunction|Memory Impairment
Interventions: DRUG: Donepezil 5 mg|DRUG: Placebo
Sponsor: Wake Forest University Health Sciences
Collaborators: National Cancer Institute (NCI)